BSD Medical’s MicroThermX-100
This article was originally published in The Gray Sheet
Executive Summary
Microwave ablation system gains 510(k) clearance for ablation of soft tissues, the firm announces Sept. 11. BSD says it developed the microwave system as a stand-alone therapy to target cancerous tissues in a minimally invasive way. The technology can be used in both surgical and percutaneous procedures, and will be pitched to surgeons and interventional radiologists, the Salt Lake City firm says